“"There is an extraordinary amount of innovation in neurotechnology right now. The hard part is not simply inventing a new device — it is working out how to get it to the people who need it most. NCNN gives us a real-world place to do that. ARIA’s investment will help build the clinical and regulatory capability needed to translate the most promising neurotechnologies, both within our programmes and across the broader ecosystem, into real-world impact."
UK Boosts Neurotechnology Research with £6.2m Investment
National Centre for Neurotechnology and Neurorestoration expands capabilities to safely evaluate and translate emerging brain technologies.
By The SME Chronicle Newsroom
••2 min read
AI
Generic image of abstract glowing neural network patterns against a dark background.
The UK is set to enhance its capacity in neurotechnology following a £6.2m investment aimed at expanding the National Centre for Neurotechnology and Neurorestoration (NCNN).
This significant funding will bolster the nation's ability to safely and effectively evaluate and translate emerging neurotechnologies. The investment comprises £3.1m from the Advanced Research and Invention Agency (ARIA), matched by Newcastle upon Tyne Hospitals NHS Foundation Trust. In collaboration with Newcastle University, these partners will scale up NCNN’s specialist workforce, facilities, and national partnerships.
Established in 2025, NCNN is the UK’s first centre dedicated to technologies that interact with the brain and nervous system. Based in Newcastle, it integrates clinical care, research, innovation, and education to assess how promising neurotechnologies can be applied in practice and, where appropriate, progress towards wider adoption.
The investment will build a nationally connected, NHS-embedded capability rather than supporting a single device or study. NCNN will consolidate expertise in clinical-study design, regulatory strategy, governance, evidence generation, training, and implementation, while also coordinating a broader network of clinical and research partners across the UK.
The centre is designed to support innovators, researchers, and NHS organisations, including ARIA’s Creator teams, who are developing new neurotechnologies.
Based on information from the official source: Advanced Research and Invention Agency (19/11/2026)



